HKHyeonjeong Kang

Hyeonjeong Kang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hyeonjeong Kang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of amplicon-based nanopore sequencing for foot-and-mouth disease viruses in clinical and environmental samples

    by Ji Hyun Jeon, Soyoon Ryoo, Hyeonjeong Kang, Jongwan Kim, Da-Rae Lim, Antonello Di Nardo, Andrew E. Shaw, Donald P. King, Su-Mi Kim

    Foot-and-mouth disease (FMD) causes severe global economic loss, necessitating rapid viral characterization. Nanopore sequencing provides a simple, real-time workflow suitable for on-site outbreak response, addressing the limitations of conventional methods. In this study, we optimized a previously published amplicon-based protocol and used this method to characterize a diverse range of samples (vesicular fluid, epithelium, serum, nasal/oral swabs, and environmental samples) collected during FMD outbreaks in 2025 in the Republic of Korea. Of the 129 samples collected, we successfully recovered complete genomes from 37 samples and VP1 sequences from 85 samples. Amplifying the S-fragment in isolation and separately barcoding each pool of PCR amplicons markedly improved sequence recovery. Furthermore, sequencing success depended on viral load and sample type. Based on comparisons with real-time RT-PCR results, whole-genome sequence (WGS) recovery exceeded 77.3% at cycle threshold (Ct) values ≤25 across all clinical samples. In the Ct > 30 category, serum samples yielded the highest WGS recovery rates (44.4%). This rate was markedly higher than the success rates observed for epithelium (20.0%) and nasal swabs (9.1%), whereas oral swabs and environmental samples failed to yield any sequences (0%). However, VP1 recovery from environmental samples reached 80% at Ct ≤ 30 (8/10), providing an approach to enable non-invasive monitoring. These findings demonstrate that amplicon-based nanopore sequencing is a practical method for the rapid generation of genomic data during FMD outbreaks. IMPORTANCE: Although rapid detection and genomic data analysis are crucial for effective foot-and-mouth disease (FMD) control, the collection of these data can be challenging for certain sample types and impacted by reduced viral loads that result from nationwide FMD vaccination. This study provides a practical solution through large-scale evaluation of an optimized amplicon-based nanopore sequencing protocol to enhance the sequencing success rates for both clinical and environmental samples. Using a modified protocol to enhance genome recovery, we demonstrated that sequence data could be retrieved from diverse sample types (even with high real-time RT-PCR cycle threshold values). We identified serum as the most suitable sample, with environmental sample sequencing allowing for non-invasive monitoring during outbreaks. These results support the use of nanopore sequencing for rapid genomic analysis, particularly in outbreak responses, such as rapid surveillance, emergency vaccine selection, and epidemiological monitoring.

  • Open Access

    Molecular characterisation of foot-and-mouth disease viruses collected from Bangladesh during 2021–23: evidence for trans-pool spread of exotic viral lineages

    by Hyeonjeong Kang, Soyoon Ryoo, Da-Rae Lim, Tae-Yoon Eom, Jae-Myung Kim, Jongwan Kim, Shukes Chandra Badhy, Mohammad Sadekuzzaman, Shamima Akter, Antonello Di Nardo, et al.

    Foot-and-mouth disease (FMD) remains endemic in Bangladesh with the persistent circulation of FMD virus (FMDV) serotypes O, A, and Asia 1, underscoring the need for robust epidemiological data to inform and optimize national FMD control strategies. This study analyzed 57 VP1 coding sequences obtained from 89 clinical samples collected from FMD-infected cattle in Bangladesh between 2021 and 2023. Phylogenetic analysis classified these field isolates into three FMDV lineages: O/ME-SA/Ind-2001e ( n = 40, 70.2%), O/ME-SA/SA-2018 ( n = 15, 26.3%), and A/ASIA/Iran-05 ( n = 2, 3.5%). The O/ME-SA/SA-2018 lineage detected in 2022 (61.1%) and 2023 (25.0%) shared 94.24–99.06% nucleotide sequence identity with viruses from the same lineage collected in 2021. Sequences for O/ME-SA/SA-2018 were monophyletic, while data for O/ME-SA/Ind-2001e provided evidence for viruses evolving within two sister clades in Bangladesh during 2021–23. Additionally, two samples collected in 2023 and tested positive for serotype A were characterized as belonging to the A/ASIA/Iran-05 lineage (sublineage FAR-11), representing the first cases of this lineage reported within the FMD endemic Pool 2. Analyses showed that VP1 sequences for two isolates (A/BAN5/2023 and A/BAN6/2023) were most closely related to a virus isolated in Pakistan during 2022 (PAK/41/2022a), sharing 97.81% nucleotide identity and a common ancestor dated March 2022. Further studies are needed to identify likely pathways of introduction of the A/Iran-05 lineage in Bangladesh, as well as to assess the potential risk to neighboring countries. This study highlights the importance of continuous FMD monitoring in Bangladesh to inform both control and vaccination strategies.